Eukaryotic messenger RNA precursors (pre-mRNAs) synthesized by RNA polymerase II (RNAP II) are processed cotranscriptionally. The carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II is thought to mediate the coupling of transcription with pre-mRNA processing by coordinating the recruitment of processing factors during synthesis of nascent transcripts. Previous studies have demonstrated that the phosphorylated CTD is required for efficient co-transcriptional processing. In the study presented here we investigated whether the CTD is sufficient to coordinate transcription with pre-mRNA capping and splicing in the context of two other DNA-dependent RNA polymerases, mammalian RNAP III and bacteriophage T7 RNAP. Our results indicate that the CTD fused to the largest subunit of RNAP III (POLR3A) is not sufficient to enhance co-transcriptional pre-mRNA splicing or capping in vivo. Additionally, we analyzed a T7 RNAP-CTD fusion protein and examined its ability to enhance pre-mRNA splicing and capping of both constitutively and alternatively spliced substrates. We observed that the CTD in the context of T7 RNAP was not sufficient to enhance pre-mRNA splicing or capping either in vitro or in vivo. We propose that the efficient coupling of transcription to pre-mRNA processing requires not only the phosphorylated CTD but also other RNAP II specific subunits or associated factors.In recent years many studies have focused on deciphering the mechanisms by which RNA polymerase II (RNAP II) 4 transcription is coupled with pre-messenger RNA (pre-mRNA) processing, including 5Ј capping, splicing, and 3Ј end formation (1-8). These studies have revealed a role of the carboxyl-terminal domain (CTD) of the largest subunit of RNAP II (POLR2A) in the coupling of transcription to pre-mRNA processing. The CTD is unique to POLR2A, as it is not present in homologous subunits of RNA polymerases I and III (9, 10). The highly conserved CTD comprises 25-52 heptapeptide repeats with the consensus sequence 1 YSPTSPS 7 . This sequence can be highly modified in vivo via glycosylation, phosphorylation, and isomerization of specific residues (11-13). The repetitive nature of the CTD and its ability to be differentially modified has led to the proposal of a CTD code (11,14). This idea suggests that the modification state of the heptapeptide repeats can serve to coordinate transcription with pre-mRNA processing by recruiting the appropriate processing factors at appropriate stages of the transcription cycle (15).CTD phosphorylation and dephosphorylation are critical for proper CTD function (15). The hypophosphorylated form of RNAP II, RNAP II a , is associated with the preinitiation complex positioned at the promoter, whereas the hyperphosphorylated form, RNAP II O , is associated with transcript elongation and pre-mRNA processing (12). The general transcription factor TFIIH phosphorylates Ser 5 residues of the CTD soon after transcription initiation. RNAP II with Ser 5 -phosphorylated CTD repeats undergoes promoter-proximal pausin...